China Health Industries Holdings (CHHE) Stock Analysis & Winston Score

China Health Industries Holdings, Inc. is a small healthcare company based in China that focuses on developing and selling health-related products, including specialty and generic drugs. Its customers are primarily consumers and distributors within the Chinese domestic market. The company operates in China's broader health and wellness industry, which includes pharmaceutical manufacturing and distribution.

The company generates revenue through product sales, but its financials show serious strain — a gross margin near zero and a deeply negative operating margin suggest it spends far more than it earns. With a market cap effectively at zero, the company is extremely small and lacks the scale, brand recognition, or proprietary technology that larger drug manufacturers use to defend their market position. The main risk facing this business is financial survival itself, as the current cost structure raises real questions about whether the company can continue operating without significant restructuring or outside capital.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-99.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+50.0% YoY

YoY Growth Rate

Strong earnings growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

31.3%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$18,100 cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

China Health Industries Holdings's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 65.5M (2019) → 65.5M (2023)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

-80106.9%

Thin — -80106.9% gross margin

Operating Margin

-163512.6%

Losing money on operations — -163512.6%

ROCE

-4.5%

Weak — -4.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

+11.4%

Steady sales growth (11.4% YoY)

EPS YoY

-100.0%

Earnings shrinking (-100.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-54111.6%

Burning cash (-54111.6%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial